doi: 10.3389/fcell.2025.1718643 Received 04 October 2025 Revised 05 November 2025 Accepted 10 November 2025 Published 21 November 2025 Volume 13 - 2025 Edited by Carol Margaret Trim, Canterbury Christ Church University, United Kingdom Reviewed by Juliano C
Christopher Shade, Ph
Interstitial cystitis: In a trial of 12 women (ages 39-76) with moderate to severe interstitial cystitis unresponsive to conventional treatment, a single 10 mg BPC-157 injection led to complete symptom resolution in 10 patients and 80% improvement in 2, with no reported adverse effects (18) Knee pain: A retrospective study found that 11 of the 12 patients (91.6%) receiving BPC 157 as an intra-articular injection had significant improvement in knee pain, whereas 1 patient (8.3 %) had no improvement (19) Efficacy of BPC 157 Delivery Methods BPC-157 can be administered orally, topically, or via injection
The mycotoxins including deoxynivalenol were found to be associated with PC2 (phosphatidylcholines) and PC10 (unknowns), while a-zearalanol was associated with PC1 (lysophosphatidylcholines, sphingomyelins, and ceramides) (Fig
Reduction in Pigmentation: People with sun spots, acne marks, or uneven patches often notice gradual fading with consistent treatment sessions
The only diagnostic in development that does not rely on ultrasound or biomarkers is the measurement of anogenital distance, a marker of in-utero endocrine exposure also investigated for endometriosis diagnosis (early development)
